BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16935616)

  • 1. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Lorenzo Carrero J; Pérez Flores I; González Barcia M
    Am J Ophthalmol; 2006 Sep; 142(3):529; author reply 529-30. PubMed ID: 16935616
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Jonas JB; Kreissig I; Spandau UH; Harder B
    Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravitreal application of triamcinolone--our experiences].
    Konjević Pernar S; Vatavuk Z; Bencić G; Pentz A; Mandić Z
    Acta Med Croatica; 2006; 60(2):133-5. PubMed ID: 16848205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Bobbili RB; Mathai A
    Am J Ophthalmol; 2006 Sep; 142(3):531; author reply 531-2. PubMed ID: 16935620
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal triamcinolone.
    Stefánsson E
    Ophthalmology; 2007 Aug; 114(8):1590; author reply 1590. PubMed ID: 17678704
    [No Abstract]   [Full Text] [Related]  

  • 8. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
    Ho TC
    Ophthalmologica; 2006; 220(6):409; author reply 410. PubMed ID: 17095890
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
    Pathai S
    Eye (Lond); 2007 Feb; 21(2):255-6. PubMed ID: 16778819
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravitreal injection of triamcinolone for diffuse macular edema.
    Rodriguez-Coleman H; Yuan P; Kim H; Gravlin L; Srivastava S; Csaky KG; Robinson MR
    Arch Ophthalmol; 2004 Jul; 122(7):1085-6; author reply 1086-8. PubMed ID: 15249388
    [No Abstract]   [Full Text] [Related]  

  • 11. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
    Aggermann T; Stolba U; Brunner S; Binder S
    Ophthalmologica; 2006; 220(2):131-3. PubMed ID: 16491037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endophthalmitis following intravitreal triamcinolone acetonid injection--a case report].
    Jamrozy-Witkowska A; Grabska-Liberek I; Kowalska K; Oficjalska-Młyńczak J
    Klin Oczna; 2010; 112(1-3):57-60. PubMed ID: 20572506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T; Uemura A; Kita H; Sakamoto T
    J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Erdinç A; Ozdek SC
    Am J Ophthalmol; 2006 Jul; 142(1):197; author reply 197-8. PubMed ID: 16815288
    [No Abstract]   [Full Text] [Related]  

  • 15. [Considerations about intravitreal triamcinolone use].
    Gómez-Ulla F; López Gálvez MI
    Arch Soc Esp Oftalmol; 2007 Jun; 82(6):327-9. PubMed ID: 17573639
    [No Abstract]   [Full Text] [Related]  

  • 16. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
    Chu YK; Chung EJ; Kwon OW; Lee JH; Koh HJ
    Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
    Ziahosseini K; Fong KC; Horgan SE
    Eye (Lond); 2006 Jul; 20(7):861-2; author reply 862-3. PubMed ID: 16096662
    [No Abstract]   [Full Text] [Related]  

  • 18. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
    Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
    Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technique of administering the intravitreal injection, and the optimum dosage required to gain a therapeutic benefit.
    Ozkiriş A
    Eye (Lond); 2007 Feb; 21(2):254-5. PubMed ID: 16878118
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Er H
    Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.